| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1259.2 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1259.2/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2 |
| Version | 20230205 |
| Status | active |
| Date | 2023-02-05T01:02:51-05:00 |
| Name | PrescribableBrandAndGenericNonInsulinDrugsForHyperglycemiaInType2Diabetes |
| Title | Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for both brand and generic prescribable non-insulin medications used to treat hyperglycemia in Type 2 Diabetes Mellitus),(Data Element Scope: Any medication data element which references prescribable, non-insulin medications used to treat hyperglycemia in Type 2 Diabetes Mellitus using SBD and SCD RxNorm TTYs),(Inclusion Criteria: Includes concepts that describe a generic or branded prescribable medication containing ingredients in the following classes: Sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, Alpha-glucosidase inhibitor. Also includes drugs containing the following ingredients: thiazolidinedione , glinide, pramlintide, metformin.),(Exclusion Criteria: Excludes concepts that describe a non-prescribable medication.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR